Silo Pharma, Inc. (SILO)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Silo Pharma, Inc.’s names, not what it holds today.
6 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Sep 18, 2025 | 2025/0288540 | METHODS AND COMPOSITIONS FOR PAIN MANAGEMENT | Pharmaceuticals | SILO PHARMA, INC. |
| Aug 1, 2024 | 2024/0252579 | USE OF CNS-HOMING TARGETING PEPTIDES FOR TREATING NEUROLOGICAL DISORDERS | Pharmaceuticals | SILO PHARMA, INC. |
| Feb 22, 2024 | 2024/0058469 | USE OF PSILOCYBIN IN CANCER TREATMENT | Pharmaceuticals | SILO PHARMA, INC. |
| Nov 2, 2023 | 2023/0346970 | CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND PSILOCYBIN | Pharmaceuticals | SILO PHARMA, INC. |
| Aug 10, 2023 | 2023/0248838 | CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS | Pharmaceuticals | SILO PHARMA, INC. |
| Aug 3, 2023 | 2023/0241231 | CENTRAL NERVOUS SYSTEM DELIVERY OF PSILOCYBIN | Pharmaceuticals | SILO PHARMA, INC. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.